ERBB2 and cancer: Notably, treated patient samples clustered—based on genes in KEGG pathways de‐regulated in cancer and involving HER2—closely with the residual mouse samples (Fig 3F) and showed similar alterations in glycolysis and the urea cycle enzymes (Fig 3G).